GO:0005654 | nucleoplasm | 3.49e-09 | 5.04e-05 | 3.447 | 9 | 64 | 1082 |
GO:0006366 | transcription from RNA polymerase II promoter | 8.08e-06 | 1.17e-01 | 3.968 | 5 | 30 | 419 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 4.11e-05 | 5.92e-01 | 7.656 | 2 | 2 | 13 |
GO:0005515 | protein binding | 6.71e-05 | 9.68e-01 | 1.260 | 11 | 198 | 6024 |
GO:0003677 | DNA binding | 1.14e-04 | 1.00e+00 | 2.691 | 6 | 49 | 1218 |
GO:0000398 | mRNA splicing, via spliceosome | 2.23e-04 | 1.00e+00 | 4.584 | 3 | 15 | 164 |
GO:0044212 | transcription regulatory region DNA binding | 2.39e-04 | 1.00e+00 | 4.549 | 3 | 17 | 168 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 2.59e-04 | 1.00e+00 | 6.357 | 2 | 2 | 32 |
GO:0003714 | transcription corepressor activity | 2.84e-04 | 1.00e+00 | 4.466 | 3 | 11 | 178 |
GO:0006355 | regulation of transcription, DNA-templated | 5.08e-04 | 1.00e+00 | 2.717 | 5 | 43 | 997 |
GO:0008380 | RNA splicing | 5.86e-04 | 1.00e+00 | 4.109 | 3 | 22 | 228 |
GO:0006986 | response to unfolded protein | 6.35e-04 | 1.00e+00 | 5.713 | 2 | 4 | 50 |
GO:0003713 | transcription coactivator activity | 6.56e-04 | 1.00e+00 | 4.053 | 3 | 24 | 237 |
GO:0008134 | transcription factor binding | 6.97e-04 | 1.00e+00 | 4.023 | 3 | 18 | 242 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:1902044 | regulation of Fas signaling pathway | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0048291 | isotype switching to IgG isotypes | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0002368 | B cell cytokine production | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 8.84e-04 | 1.00e+00 | 5.474 | 2 | 6 | 59 |
GO:0005634 | nucleus | 8.85e-04 | 1.00e+00 | 1.372 | 9 | 159 | 4559 |
GO:0010467 | gene expression | 1.17e-03 | 1.00e+00 | 2.971 | 4 | 45 | 669 |
GO:0019948 | SUMO activating enzyme activity | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0060242 | contact inhibition | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0019046 | release from viral latency | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 2 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0031510 | SUMO activating enzyme complex | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0019950 | SMT3-dependent protein catabolic process | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0050821 | protein stabilization | 1.95e-03 | 1.00e+00 | 4.897 | 2 | 3 | 88 |
GO:0006458 | 'de novo' protein folding | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0030135 | coated vesicle | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0034340 | response to type I interferon | 3.05e-03 | 1.00e+00 | 8.357 | 1 | 1 | 4 |
GO:0004839 | ubiquitin activating enzyme activity | 3.05e-03 | 1.00e+00 | 8.357 | 1 | 1 | 4 |
GO:0070461 | SAGA-type complex | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 2 | 5 |
GO:0001714 | endodermal cell fate specification | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0046696 | lipopolysaccharide receptor complex | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 2 | 5 |
GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0003688 | DNA replication origin binding | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 6 |
GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 6 |
GO:0070087 | chromo shadow domain binding | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 3 | 6 |
GO:0030870 | Mre11 complex | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 6 |
GO:0051271 | negative regulation of cellular component movement | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 6 |
GO:0046826 | negative regulation of protein export from nucleus | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 2 | 7 |
GO:0043008 | ATP-dependent protein binding | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 1 | 7 |
GO:0005829 | cytosol | 5.58e-03 | 1.00e+00 | 1.656 | 6 | 86 | 2496 |
GO:0006974 | cellular response to DNA damage stimulus | 5.63e-03 | 1.00e+00 | 4.118 | 2 | 7 | 151 |
GO:0001055 | RNA polymerase II activity | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 3 | 8 |
GO:0001955 | blood vessel maturation | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 8 |
GO:0043254 | regulation of protein complex assembly | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 8 |
GO:0051604 | protein maturation | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 2 | 8 |
GO:0044822 | poly(A) RNA binding | 6.21e-03 | 1.00e+00 | 2.312 | 4 | 50 | 1056 |
GO:0016032 | viral process | 6.67e-03 | 1.00e+00 | 2.881 | 3 | 26 | 534 |
GO:0043995 | histone acetyltransferase activity (H4-K5 specific) | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 5 | 9 |
GO:0046972 | histone acetyltransferase activity (H4-K16 specific) | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 5 | 9 |
GO:0048188 | Set1C/COMPASS complex | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 4 | 9 |
GO:0006983 | ER overload response | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 9 |
GO:0043996 | histone acetyltransferase activity (H4-K8 specific) | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 5 | 9 |
GO:0035413 | positive regulation of catenin import into nucleus | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 2 | 10 |
GO:0043032 | positive regulation of macrophage activation | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 1 | 10 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 8.25e-03 | 1.00e+00 | 3.833 | 2 | 22 | 184 |
GO:0032727 | positive regulation of interferon-alpha production | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 1 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 3 | 11 |
GO:0001054 | RNA polymerase I activity | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 3 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 4 | 11 |
GO:0005736 | DNA-directed RNA polymerase I complex | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 3 | 12 |
GO:0032897 | negative regulation of viral transcription | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 12 |
GO:0034399 | nuclear periphery | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 5 | 12 |
GO:0035198 | miRNA binding | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 12 |
GO:0071480 | cellular response to gamma radiation | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 13 |
GO:0001530 | lipopolysaccharide binding | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 13 |
GO:0051131 | chaperone-mediated protein complex assembly | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 13 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 1 | 14 |
GO:0010596 | negative regulation of endothelial cell migration | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 1 | 14 |
GO:0031011 | Ino80 complex | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 6 | 14 |
GO:0043981 | histone H4-K5 acetylation | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 5 | 15 |
GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 3 | 15 |
GO:0048384 | retinoic acid receptor signaling pathway | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 1 | 15 |
GO:0001824 | blastocyst development | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 2 | 15 |
GO:0043982 | histone H4-K8 acetylation | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 5 | 15 |
GO:0042026 | protein refolding | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 1 | 15 |
GO:0043274 | phospholipase binding | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 16 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 4 | 16 |
GO:0001056 | RNA polymerase III activity | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 3 | 16 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.29e-02 | 1.00e+00 | 6.269 | 1 | 3 | 17 |
GO:0050870 | positive regulation of T cell activation | 1.29e-02 | 1.00e+00 | 6.269 | 1 | 1 | 17 |
GO:0006386 | termination of RNA polymerase III transcription | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 3 | 18 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 3 | 18 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 1.40e-02 | 1.00e+00 | 2.492 | 3 | 39 | 699 |
GO:0032733 | positive regulation of interleukin-10 production | 1.44e-02 | 1.00e+00 | 6.109 | 1 | 2 | 19 |
GO:0043984 | histone H4-K16 acetylation | 1.44e-02 | 1.00e+00 | 6.109 | 1 | 5 | 19 |
GO:0032757 | positive regulation of interleukin-8 production | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 1 | 20 |
GO:0042100 | B cell proliferation | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 1 | 21 |
GO:0000123 | histone acetyltransferase complex | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 6 | 21 |
GO:0034341 | response to interferon-gamma | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 2 | 21 |
GO:0006281 | DNA repair | 1.61e-02 | 1.00e+00 | 3.329 | 2 | 14 | 261 |
GO:0045787 | positive regulation of cell cycle | 1.67e-02 | 1.00e+00 | 5.897 | 1 | 2 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.67e-02 | 1.00e+00 | 5.897 | 1 | 2 | 22 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 1.67e-02 | 1.00e+00 | 5.897 | 1 | 4 | 22 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.74e-02 | 1.00e+00 | 5.833 | 1 | 1 | 23 |
GO:0045765 | regulation of angiogenesis | 1.82e-02 | 1.00e+00 | 5.772 | 1 | 2 | 24 |
GO:0003899 | DNA-directed RNA polymerase activity | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 3 | 25 |
GO:0016925 | protein sumoylation | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 2 | 25 |
GO:0042113 | B cell activation | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 2 | 25 |
GO:0032735 | positive regulation of interleukin-12 production | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 2 | 25 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.93e-02 | 1.00e+00 | 2.318 | 3 | 41 | 789 |
GO:0043392 | negative regulation of DNA binding | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 4 | 26 |
GO:0035329 | hippo signaling | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 5 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 1 | 26 |
GO:0071339 | MLL1 complex | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 6 | 27 |
GO:0007346 | regulation of mitotic cell cycle | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 29 |
GO:0006360 | transcription from RNA polymerase I promoter | 2.27e-02 | 1.00e+00 | 5.450 | 1 | 3 | 30 |
GO:0006370 | 7-methylguanosine mRNA capping | 2.27e-02 | 1.00e+00 | 5.450 | 1 | 5 | 30 |
GO:0042594 | response to starvation | 2.34e-02 | 1.00e+00 | 5.402 | 1 | 4 | 31 |
GO:0003723 | RNA binding | 2.68e-02 | 1.00e+00 | 2.939 | 2 | 18 | 342 |
GO:0032755 | positive regulation of interleukin-6 production | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 2 | 36 |
GO:0043565 | sequence-specific DNA binding | 2.74e-02 | 1.00e+00 | 2.922 | 2 | 11 | 346 |
GO:0005730 | nucleolus | 2.86e-02 | 1.00e+00 | 1.676 | 4 | 66 | 1641 |
GO:0032729 | positive regulation of interferon-gamma production | 2.94e-02 | 1.00e+00 | 5.071 | 1 | 1 | 39 |
GO:0006383 | transcription from RNA polymerase III promoter | 2.94e-02 | 1.00e+00 | 5.071 | 1 | 3 | 39 |
GO:0008047 | enzyme activator activity | 2.94e-02 | 1.00e+00 | 5.071 | 1 | 3 | 39 |
GO:0035019 | somatic stem cell maintenance | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 6 | 40 |
GO:0042110 | T cell activation | 3.16e-02 | 1.00e+00 | 4.964 | 1 | 1 | 42 |
GO:0031124 | mRNA 3'-end processing | 3.16e-02 | 1.00e+00 | 4.964 | 1 | 2 | 42 |
GO:0046982 | protein heterodimerization activity | 3.25e-02 | 1.00e+00 | 2.787 | 2 | 8 | 380 |
GO:0050434 | positive regulation of viral transcription | 3.31e-02 | 1.00e+00 | 4.897 | 1 | 5 | 44 |
GO:0006369 | termination of RNA polymerase II transcription | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 2 | 45 |
GO:0043525 | positive regulation of neuron apoptotic process | 3.45e-02 | 1.00e+00 | 4.833 | 1 | 4 | 46 |
GO:0032526 | response to retinoic acid | 3.45e-02 | 1.00e+00 | 4.833 | 1 | 1 | 46 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 3.45e-02 | 1.00e+00 | 4.833 | 1 | 4 | 46 |
GO:0009986 | cell surface | 3.61e-02 | 1.00e+00 | 2.706 | 2 | 9 | 402 |
GO:0034097 | response to cytokine | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 2 | 50 |
GO:0005905 | coated pit | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 6 | 50 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.79e-02 | 1.00e+00 | 2.667 | 2 | 24 | 413 |
GO:0034976 | response to endoplasmic reticulum stress | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 1 | 51 |
GO:0003725 | double-stranded RNA binding | 3.90e-02 | 1.00e+00 | 4.656 | 1 | 1 | 52 |
GO:0009611 | response to wounding | 3.90e-02 | 1.00e+00 | 4.656 | 1 | 5 | 52 |
GO:0019900 | kinase binding | 3.90e-02 | 1.00e+00 | 4.656 | 1 | 1 | 52 |
GO:0002039 | p53 binding | 4.12e-02 | 1.00e+00 | 4.575 | 1 | 4 | 55 |
GO:0000723 | telomere maintenance | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 1 | 56 |
GO:0005737 | cytoplasm | 4.20e-02 | 1.00e+00 | 1.062 | 6 | 124 | 3767 |
GO:0060337 | type I interferon signaling pathway | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 2 | 58 |
GO:0006396 | RNA processing | 4.41e-02 | 1.00e+00 | 4.474 | 1 | 5 | 59 |
GO:0051087 | chaperone binding | 4.41e-02 | 1.00e+00 | 4.474 | 1 | 3 | 59 |
GO:0032481 | positive regulation of type I interferon production | 4.56e-02 | 1.00e+00 | 4.426 | 1 | 6 | 61 |
GO:0006406 | mRNA export from nucleus | 4.56e-02 | 1.00e+00 | 4.426 | 1 | 4 | 61 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 4.56e-02 | 1.00e+00 | 4.426 | 1 | 2 | 61 |
GO:0043085 | positive regulation of catalytic activity | 4.56e-02 | 1.00e+00 | 4.426 | 1 | 2 | 61 |
GO:0060333 | interferon-gamma-mediated signaling pathway | 4.63e-02 | 1.00e+00 | 4.402 | 1 | 3 | 62 |
GO:0030141 | secretory granule | 4.63e-02 | 1.00e+00 | 4.402 | 1 | 4 | 62 |
GO:0006310 | DNA recombination | 4.85e-02 | 1.00e+00 | 4.334 | 1 | 7 | 65 |
GO:0044267 | cellular protein metabolic process | 4.87e-02 | 1.00e+00 | 2.468 | 2 | 20 | 474 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.95e-02 | 1.00e+00 | 2.456 | 2 | 24 | 478 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 4.99e-02 | 1.00e+00 | 4.291 | 1 | 6 | 67 |
GO:0042802 | identical protein binding | 5.06e-02 | 1.00e+00 | 2.438 | 2 | 19 | 484 |
GO:0006289 | nucleotide-excision repair | 5.07e-02 | 1.00e+00 | 4.269 | 1 | 5 | 68 |
GO:0010468 | regulation of gene expression | 5.07e-02 | 1.00e+00 | 4.269 | 1 | 2 | 68 |
GO:0003697 | single-stranded DNA binding | 5.07e-02 | 1.00e+00 | 4.269 | 1 | 5 | 68 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 4 | 74 |
GO:0002020 | protease binding | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 6 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 5.58e-02 | 1.00e+00 | 4.128 | 1 | 1 | 75 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 5.72e-02 | 1.00e+00 | 4.090 | 1 | 3 | 77 |
GO:0071013 | catalytic step 2 spliceosome | 5.79e-02 | 1.00e+00 | 4.071 | 1 | 7 | 78 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 5.86e-02 | 1.00e+00 | 4.053 | 1 | 2 | 79 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 5.94e-02 | 1.00e+00 | 4.035 | 1 | 5 | 80 |
GO:0009653 | anatomical structure morphogenesis | 6.15e-02 | 1.00e+00 | 3.982 | 1 | 2 | 83 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 6.37e-02 | 1.00e+00 | 3.930 | 1 | 8 | 86 |
GO:0016605 | PML body | 6.51e-02 | 1.00e+00 | 3.897 | 1 | 3 | 88 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 6.77e-02 | 1.00e+00 | 2.202 | 2 | 37 | 570 |
GO:0001649 | osteoblast differentiation | 6.80e-02 | 1.00e+00 | 3.833 | 1 | 5 | 92 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 6.80e-02 | 1.00e+00 | 3.833 | 1 | 7 | 92 |
GO:0005770 | late endosome | 6.87e-02 | 1.00e+00 | 3.817 | 1 | 2 | 93 |
GO:0051082 | unfolded protein binding | 6.87e-02 | 1.00e+00 | 3.817 | 1 | 7 | 93 |
GO:0030529 | ribonucleoprotein complex | 8.22e-02 | 1.00e+00 | 3.549 | 1 | 5 | 112 |
GO:0006325 | chromatin organization | 8.64e-02 | 1.00e+00 | 3.474 | 1 | 12 | 118 |
GO:0007050 | cell cycle arrest | 9.06e-02 | 1.00e+00 | 3.402 | 1 | 5 | 124 |
GO:0016055 | Wnt signaling pathway | 1.00e-01 | 1.00e+00 | 3.248 | 1 | 4 | 138 |
GO:0016887 | ATPase activity | 1.02e-01 | 1.00e+00 | 3.227 | 1 | 1 | 140 |
GO:0010628 | positive regulation of gene expression | 1.06e-01 | 1.00e+00 | 3.167 | 1 | 7 | 146 |
GO:0005769 | early endosome | 1.10e-01 | 1.00e+00 | 3.109 | 1 | 1 | 152 |
GO:0008022 | protein C-terminus binding | 1.16e-01 | 1.00e+00 | 3.026 | 1 | 8 | 161 |
GO:0043687 | post-translational protein modification | 1.17e-01 | 1.00e+00 | 3.017 | 1 | 5 | 162 |
GO:0016607 | nuclear speck | 1.24e-01 | 1.00e+00 | 2.930 | 1 | 12 | 172 |
GO:0007049 | cell cycle | 1.25e-01 | 1.00e+00 | 2.914 | 1 | 6 | 174 |
GO:0005667 | transcription factor complex | 1.26e-01 | 1.00e+00 | 2.905 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 1.28e-01 | 1.00e+00 | 2.881 | 1 | 5 | 178 |
GO:0016020 | membrane | 1.28e-01 | 1.00e+00 | 1.227 | 3 | 46 | 1681 |
GO:0019904 | protein domain specific binding | 1.28e-01 | 1.00e+00 | 2.873 | 1 | 8 | 179 |
GO:0019221 | cytokine-mediated signaling pathway | 1.56e-01 | 1.00e+00 | 2.569 | 1 | 8 | 221 |
GO:0005759 | mitochondrial matrix | 1.61e-01 | 1.00e+00 | 2.524 | 1 | 4 | 228 |
GO:0043025 | neuronal cell body | 1.72e-01 | 1.00e+00 | 2.420 | 1 | 9 | 245 |
GO:0005739 | mitochondrion | 1.74e-01 | 1.00e+00 | 1.394 | 2 | 23 | 998 |
GO:0000166 | nucleotide binding | 1.81e-01 | 1.00e+00 | 2.340 | 1 | 13 | 259 |
GO:0043065 | positive regulation of apoptotic process | 1.86e-01 | 1.00e+00 | 2.291 | 1 | 7 | 268 |
GO:0005743 | mitochondrial inner membrane | 1.92e-01 | 1.00e+00 | 2.243 | 1 | 6 | 277 |
GO:0006954 | inflammatory response | 1.92e-01 | 1.00e+00 | 2.243 | 1 | 6 | 277 |
GO:0006200 | ATP catabolic process | 2.02e-01 | 1.00e+00 | 2.167 | 1 | 2 | 292 |
GO:0043234 | protein complex | 2.03e-01 | 1.00e+00 | 2.152 | 1 | 11 | 295 |
GO:0016567 | protein ubiquitination | 2.03e-01 | 1.00e+00 | 2.152 | 1 | 4 | 295 |
GO:0043231 | intracellular membrane-bounded organelle | 2.18e-01 | 1.00e+00 | 2.044 | 1 | 6 | 318 |
GO:0003682 | chromatin binding | 2.23e-01 | 1.00e+00 | 2.004 | 1 | 19 | 327 |
GO:0008283 | cell proliferation | 2.24e-01 | 1.00e+00 | 1.999 | 1 | 14 | 328 |
GO:0005524 | ATP binding | 2.60e-01 | 1.00e+00 | 1.015 | 2 | 31 | 1298 |
GO:0043066 | negative regulation of apoptotic process | 2.80e-01 | 1.00e+00 | 1.629 | 1 | 16 | 424 |
GO:0042803 | protein homodimerization activity | 3.71e-01 | 1.00e+00 | 1.140 | 1 | 19 | 595 |
GO:0045087 | innate immune response | 3.71e-01 | 1.00e+00 | 1.137 | 1 | 15 | 596 |
GO:0005615 | extracellular space | 5.30e-01 | 1.00e+00 | 0.454 | 1 | 20 | 957 |
GO:0006351 | transcription, DNA-templated | 6.87e-01 | 1.00e+00 | -0.141 | 1 | 57 | 1446 |
GO:0070062 | extracellular vesicular exosome | 8.65e-01 | 1.00e+00 | -0.872 | 1 | 57 | 2400 |
GO:0005886 | plasma membrane | 8.86e-01 | 1.00e+00 | -0.978 | 1 | 49 | 2582 |